<DOC>
<DOCNO>
EP-0000034
</DOCNO>
<TEXT>
<DATE>
19781220
</DATE>
<IPC-CLASSIFICATIONS>
C07C-219/28 A61K-31/195 C07C-93/26 C07C-45/00 A61K-31/135 C07C-45/48 C07C-229/36 C07C-229/00 C07D-233/78 C07C-227/24 C07C-67/00 A61K-31/215 C07C-227/00 C07C-219/00 C07C-49/00 C07D-233/00 A61K-31/185 A61P-9/00 <main>C07C-91/32</main> A61P-9/12 C07C-49/255 A61K-31/21 A61P-43/00 
</IPC-CLASSIFICATIONS>
<TITLE>
fluorinated amines, compositions and process for preparing said compounds.
</TITLE>
<APPLICANT>
merck & co incus   <sep>merck & co. inc.<sep>merck &amp; co., inc.126, east lincoln avenue p.o. box 2000rahway new jersey 07065-0900us<sep>merck & co inc us  <sep>merck & co. inc.<sep>
</APPLICANT>
<INVENTOR>
kollonitsch janos<sep>marburg stephen<sep>patchett arthur allan<sep>kollonitsch, janos<sep>marburg, stephen<sep>patchett, arthur allan<sep>kollonitsch, janos3 plymouth roadwestfield, n.j.us<sep>marburg, stephen50 concord avenuemetuchen, n.j.us<sep>patchett, arthur allan207 oak lanecranford, n.j.us<sep>kollonitsch, janos<sep>marburg, stephen<sep>patchett, arthur allan<sep>kollonitsch, janos3 plymouth roadwestfield, n.j.us<sep>marburg, stephen50 concord avenuemetuchen, n.j.us<sep>patchett, arthur allan207 oak lanecranford, n.j.us<sep>
</INVENTOR>
<ABSTRACT>
α-difluoromethyl-3,4-di- or-phenylalanines and its  esters, and (1-difluoromethyl)- and 1-(trifluoromethyl)-2-(3,4-di-or- phenyl)  ethylamines, wherein r is hydrogen or a  c₂-c₆ alkanoyl, have been prepared.  homoveratric acid is transformed into veratryl-difluoromethyl- ketone  or veratryl- trifluoro- methyl- ketone,  this reacts with methoxyamine, and the obtained o-methyl-oxime  is reduced to the amine.  the 3- and  4-methoxygroups are hydrolysed into hydroxy-groups.  reaction of veratryl- difluoromethylketone with  ammonium-carbonate and sodium cyanide yields  α-difluoromethyl-5-(3′, 4′-dimethoxybenzyl)-2,4-imidazolidine-dione,  hydrolysis results in  α-difluoromethyl-3- hydroxytyrosine.  the compounds have  dopa-decarboxylase inhibiting activity and some of them are  antihypertensive agents.  
</ABSTRACT>
</TEXT>
</DOC>
